An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma. - Raj SS; Fei T; Fried S; Ip A; Fein JA; Leslie LA; Alarcon Tomas A; Leithner D; Peled JU; Corona M; Dahi PB; Danylesko I; et al. (Nature medicine, 2025)